Published in
American Association for the Advancement of Science, Science Immunology, 29(3), 2018
DOI: 10.1126/sciimmunol.aao2892
Links
Tools
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell–mediated control of HIV-1, HCV, and HTLV-1
Journal article published in 2018 by
Lies Boelen 
,
Bisrat Debebe ,
Marcos Silveira,
Arafa Salam,
Julia Makinde ,
Chrissy H. Roberts ,
Eddie C. Y. Wang ,
John Frater ,
Jill Gilmour,
Katie Twigger,
Kristin Ladell ,
Kelly L. Miners,
Jyothi Jayaraman,
James A. Traherne ,
David A. Price
and other authors.
,
Bisrat Debebe ,
Marcos Silveira,
Arafa Salam,
Julia Makinde ,
Chrissy H. Roberts ,
Eddie C. Y. Wang ,
John Frater ,
Jill Gilmour,
Katie Twigger,
Kristin Ladell ,
Kelly L. Miners,
Jyothi Jayaraman,
James A. Traherne ,
David A. Price
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Inhibitory killer cell immunoglobulin-like receptors (iKIRs) help maintain CD8 + T cell responses to human chronic viral infections.